Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageDebt RatioDebt to EquityEnterprise ValueEquity RatioInvested CapitalReturn on AssetsReturn on Capital Employed

Cardiol Therapeutics (CRDL) Assets Average (2021 - 2026)

Cardiol Therapeutics filings provide 2 years of Assets Average readings, the most recent being $49.1 million for Q4 2022.

  • On a quarterly basis, Assets Average rose 3.36% to $49.1 million in Q4 2022 year-over-year; TTM through Dec 2022 was $49.1 million, a 3.36% increase, with the full-year FY2022 number at $57.7 million, up 40.91% from a year prior.
  • Assets Average hit $49.1 million in Q4 2022 for Cardiol Therapeutics, down from $55.3 million in the prior quarter.
  • In the past five years, Assets Average ranged from a high of $66.2 million in Q1 2022 to a low of $27.6 million in Q3 2021.